Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
452
archived clinical trials in
Erectile Dysfunction

Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
John Muir/Mt. Diablo Comprehensive Cancer Center
mi
from
Walnut Creek, CA
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
John Muir/Mt. Diablo Comprehensive Cancer Center
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Cape Cod Hospital
mi
from
Hyannis, MA
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Cape Cod Hospital
mi
from
Hyannis, MA
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
West Michigan Cancer Center
mi
from
Kalamazoo, MI
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
West Michigan Cancer Center
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
St. John's Regional Health Center
mi
from
Springfield, MO
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
St. John's Regional Health Center
mi
from
Springfield, MO
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Hulston Cancer Center at Cox Medical Center South
mi
from
Springfield, MO
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Hulston Cancer Center at Cox Medical Center South
mi
from
Springfield, MO
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Washoe Cancer Services at Washoe Medical Center - Reno
mi
from
Reno, NV
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Washoe Cancer Services at Washoe Medical Center - Reno
mi
from
Reno, NV
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
mi
from
Lebanon, NH
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Fox Chase Virtua Health Cancer Program - Marlton
mi
from
Marlton, NJ
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Fox Chase Virtua Health Cancer Program - Marlton
mi
from
Marlton, NJ
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Community Regional Cancer Center at Community Medical Center
mi
from
Toms River, NJ
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Community Regional Cancer Center at Community Medical Center
mi
from
Toms River, NJ
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
CCOP - North Shore University Hospital
mi
from
Manhasset, NY
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
CCOP - North Shore University Hospital
mi
from
Manhasset, NY
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Akron City Hospital
mi
from
Akron, OH
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Akron City Hospital
mi
from
Akron, OH
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Cancer Research UK Medical Oncology Unit at Churchill Hospital & Weatherall Institute of Molecular Medicine - Oxford
mi
from
Salem, OH
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Cancer Research UK Medical Oncology Unit at Churchill Hospital & Weatherall Institute of Molecular Medicine - Oxford
mi
from
Salem, OH
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Cancer Treatment Center
mi
from
Wooster, OH
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Cancer Treatment Center
mi
from
Wooster, OH
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
LaFortune Cancer Center at St. John Medical Center
mi
from
Tulsa, OK
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
LaFortune Cancer Center at St. John Medical Center
mi
from
Tulsa, OK
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Natalie Warren Bryant Cancer Center at St. Francis Hospital
mi
from
Tulsa, OK
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Natalie Warren Bryant Cancer Center at St. Francis Hospital
mi
from
Tulsa, OK
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Bryn Mawr Hospital
mi
from
Bryn Mawr, PA
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Bryn Mawr Hospital
mi
from
Bryn Mawr, PA
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Paoli Memorial Hospital
mi
from
Paoli, PA
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Paoli Memorial Hospital
mi
from
Paoli, PA
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Albert Einstein Cancer Center
mi
from
Philadelphia, PA
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Albert Einstein Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
CCOP - MainLine Health
mi
from
Wynnewood, PA
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
CCOP - MainLine Health
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Lankenau Cancer Center at Lankenau Hospital
mi
from
Wynnewood, PA
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Lankenau Cancer Center at Lankenau Hospital
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
LDS Hospital
mi
from
Salt Lake City, UT
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
LDS Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Naval Medical Center - Portsmouth
mi
from
Portsmouth, VA
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Naval Medical Center - Portsmouth
mi
from
Portsmouth, VA
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center
mi
from
La Crosse, WI
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Gundersen Lutheran Cancer Center at Gundersen Lutheran Medical Center
mi
from
La Crosse, WI
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Community Memorial Hospital
mi
from
Menomonee Falls, WI
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Community Memorial Hospital
mi
from
Menomonee Falls, WI
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Medical College of Wisconsin Cancer Center
mi
from
Milwaukee, WI
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Medical College of Wisconsin Cancer Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated:  11/14/2015
Veterans Affairs Medical Center - Milwaukee (Zablocki)
mi
from
Milwaukee, WI
Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer
Treatment Of Erectile Dysfunction In Patients Treated On RTOG-9910 For Prostate Cancer: Impact On Patient And Partner Quality Of Life
Status: Enrolling
Updated: 11/14/2015
Veterans Affairs Medical Center - Milwaukee (Zablocki)
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Safety and Feasibility of the Zotarolimus Stent in Treating Males With Erectile Dysfunction (ED)
The Medtronic Zotarolimus-Eluting Peripheral Stent System for the Treatment of Erectile Dysfunction in Males With Sub-optimal Response to PDE5 Inhibitors
Status: Enrolling
Updated:  1/25/2016
Prairie Education and Research Cooperative
mi
from
Springfield, IL
Safety and Feasibility of the Zotarolimus Stent in Treating Males With Erectile Dysfunction (ED)
The Medtronic Zotarolimus-Eluting Peripheral Stent System for the Treatment of Erectile Dysfunction in Males With Sub-optimal Response to PDE5 Inhibitors
Status: Enrolling
Updated: 1/25/2016
Prairie Education and Research Cooperative
mi
from
Springfield, IL
Click here to add this to my saved trials
Incidence of Male Pudendal Artery Stenosis in Suboptimal Erections Study
Incidence of Male Pudendal Artery Stenosis in Suboptimal Erections Study
Status: Enrolling
Updated:  1/28/2016
Prairie Edication and Research Cooperative
mi
from
Springfield, IL
Incidence of Male Pudendal Artery Stenosis in Suboptimal Erections Study
Incidence of Male Pudendal Artery Stenosis in Suboptimal Erections Study
Status: Enrolling
Updated: 1/28/2016
Prairie Edication and Research Cooperative
mi
from
Springfield, IL
Click here to add this to my saved trials
ARIES for Vasculogenic Erectile Dysfunction
Low-Intensity Extracorporeal Shock Wave Therapy for the Treatment of Vasculogenic Erectile Dysfunction
Status: Enrolling
Updated:  4/19/2016
San Diego Sexual Medicine
mi
from
San Diego, CA
ARIES for Vasculogenic Erectile Dysfunction
Low-Intensity Extracorporeal Shock Wave Therapy for the Treatment of Vasculogenic Erectile Dysfunction
Status: Enrolling
Updated: 4/19/2016
San Diego Sexual Medicine
mi
from
San Diego, CA
Click here to add this to my saved trials
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
Status: Enrolling
Updated:  8/10/2016
Hudson Heart Group, PC
mi
from
Guttenberg, NJ
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
Status: Enrolling
Updated: 8/10/2016
Hudson Heart Group, PC
mi
from
Guttenberg, NJ
Click here to add this to my saved trials
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
Status: Enrolling
Updated:  8/10/2016
Elmhurst Hospital
mi
from
Elmhurst, NY
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
Status: Enrolling
Updated: 8/10/2016
Elmhurst Hospital
mi
from
Elmhurst, NY
Click here to add this to my saved trials
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
Status: Enrolling
Updated:  8/10/2016
Winthorp University Hospital
mi
from
Mineola, NY
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
Status: Enrolling
Updated: 8/10/2016
Winthorp University Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
Status: Enrolling
Updated:  8/10/2016
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
Status: Enrolling
Updated: 8/10/2016
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
Status: Enrolling
Updated:  8/10/2016
Stony Brook University Hospital
mi
from
Stony Brook, NY
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
Status: Enrolling
Updated: 8/10/2016
Stony Brook University Hospital
mi
from
Stony Brook, NY
Click here to add this to my saved trials
MRI Temperature Mapping of the Prostate and Urogenital Pelvis Cooled by an Endorectal Balloon
MRI (Magnetic Resonance Imaging) Temperature Mapping of the Prostate and Urogenital Pelvis Cooled by an Endorectal Balloon
Status: Enrolling
Updated:  12/12/2016
University of California, Irvine Medical Center
mi
from
Orange, CA
MRI Temperature Mapping of the Prostate and Urogenital Pelvis Cooled by an Endorectal Balloon
MRI (Magnetic Resonance Imaging) Temperature Mapping of the Prostate and Urogenital Pelvis Cooled by an Endorectal Balloon
Status: Enrolling
Updated: 12/12/2016
University of California, Irvine Medical Center
mi
from
Orange, CA
Click here to add this to my saved trials
Health Interventions in Men Undergoing Radical Prostatectomy
Health Interventions in Men Undergoing Radical Prostatectomy- A Randomized Controlled Clinical Trial
Status: Enrolling
Updated:  1/25/2017
Johns Hopkins Hospital
mi
from
Baltimore, MD
Health Interventions in Men Undergoing Radical Prostatectomy
Health Interventions in Men Undergoing Radical Prostatectomy- A Randomized Controlled Clinical Trial
Status: Enrolling
Updated: 1/25/2017
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Vacuum Erection Device in Improving Recovery of Erectile Function in Patients With Prostate Cancer Undergoing Surgery
Analysis of Technique Comparison With a Vacuum Erection Device as Part of an Erectile Rehabilitation Program Following Robotic Radical Prostatectomy: A Randomized Comparison of Methodology
Status: Enrolling
Updated:  4/12/2017
Ohio State University Medical Center
mi
from
Columbus, OH
Vacuum Erection Device in Improving Recovery of Erectile Function in Patients With Prostate Cancer Undergoing Surgery
Analysis of Technique Comparison With a Vacuum Erection Device as Part of an Erectile Rehabilitation Program Following Robotic Radical Prostatectomy: A Randomized Comparison of Methodology
Status: Enrolling
Updated: 4/12/2017
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy, Safety, and Duration of Erection of Flexible-dose Vardenafil Administered for 12 Weeks Compared to Placebo in Subjects With Erectile Dysfunction and Dyslipidemia
Status: Enrolling
Updated:  8/14/2017
GSK Investigational Site
mi
from
Fairhope, AL
A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy, Safety, and Duration of Erection of Flexible-dose Vardenafil Administered for 12 Weeks Compared to Placebo in Subjects With Erectile Dysfunction and Dyslipidemia
Status: Enrolling
Updated: 8/14/2017
GSK Investigational Site
mi
from
Fairhope, AL
Click here to add this to my saved trials
A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy, Safety, and Duration of Erection of Flexible-dose Vardenafil Administered for 12 Weeks Compared to Placebo in Subjects With Erectile Dysfunction and Dyslipidemia
Status: Enrolling
Updated:  8/14/2017
GSK Investigational Site
mi
from
Homewood, AL
A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy, Safety, and Duration of Erection of Flexible-dose Vardenafil Administered for 12 Weeks Compared to Placebo in Subjects With Erectile Dysfunction and Dyslipidemia
Status: Enrolling
Updated: 8/14/2017
GSK Investigational Site
mi
from
Homewood, AL
Click here to add this to my saved trials
A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy, Safety, and Duration of Erection of Flexible-dose Vardenafil Administered for 12 Weeks Compared to Placebo in Subjects With Erectile Dysfunction and Dyslipidemia
Status: Enrolling
Updated:  8/14/2017
GSK Investigational Site
mi
from
Huntsville, AL
A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy, Safety, and Duration of Erection of Flexible-dose Vardenafil Administered for 12 Weeks Compared to Placebo in Subjects With Erectile Dysfunction and Dyslipidemia
Status: Enrolling
Updated: 8/14/2017
GSK Investigational Site
mi
from
Huntsville, AL
Click here to add this to my saved trials
A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy, Safety, and Duration of Erection of Flexible-dose Vardenafil Administered for 12 Weeks Compared to Placebo in Subjects With Erectile Dysfunction and Dyslipidemia
Status: Enrolling
Updated:  8/14/2017
GSK Investigational Site
mi
from
Phoenix, AZ
A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy, Safety, and Duration of Erection of Flexible-dose Vardenafil Administered for 12 Weeks Compared to Placebo in Subjects With Erectile Dysfunction and Dyslipidemia
Status: Enrolling
Updated: 8/14/2017
GSK Investigational Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy, Safety, and Duration of Erection of Flexible-dose Vardenafil Administered for 12 Weeks Compared to Placebo in Subjects With Erectile Dysfunction and Dyslipidemia
Status: Enrolling
Updated:  8/14/2017
GSK Investigational Site
mi
from
Concord, CA
A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy, Safety, and Duration of Erection of Flexible-dose Vardenafil Administered for 12 Weeks Compared to Placebo in Subjects With Erectile Dysfunction and Dyslipidemia
Status: Enrolling
Updated: 8/14/2017
GSK Investigational Site
mi
from
Concord, CA
Click here to add this to my saved trials
A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy, Safety, and Duration of Erection of Flexible-dose Vardenafil Administered for 12 Weeks Compared to Placebo in Subjects With Erectile Dysfunction and Dyslipidemia
Status: Enrolling
Updated:  8/14/2017
GSK Investigational Site
mi
from
Huntington Park, CA
A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy, Safety, and Duration of Erection of Flexible-dose Vardenafil Administered for 12 Weeks Compared to Placebo in Subjects With Erectile Dysfunction and Dyslipidemia
Status: Enrolling
Updated: 8/14/2017
GSK Investigational Site
mi
from
Huntington Park, CA
Click here to add this to my saved trials
A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy, Safety, and Duration of Erection of Flexible-dose Vardenafil Administered for 12 Weeks Compared to Placebo in Subjects With Erectile Dysfunction and Dyslipidemia
Status: Enrolling
Updated:  8/14/2017
GSK Investigational Site
mi
from
Long Beach, CA
A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy, Safety, and Duration of Erection of Flexible-dose Vardenafil Administered for 12 Weeks Compared to Placebo in Subjects With Erectile Dysfunction and Dyslipidemia
Status: Enrolling
Updated: 8/14/2017
GSK Investigational Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy, Safety, and Duration of Erection of Flexible-dose Vardenafil Administered for 12 Weeks Compared to Placebo in Subjects With Erectile Dysfunction and Dyslipidemia
Status: Enrolling
Updated:  8/14/2017
GSK Investigational Site
mi
from
Modesto, CA
A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy, Safety, and Duration of Erection of Flexible-dose Vardenafil Administered for 12 Weeks Compared to Placebo in Subjects With Erectile Dysfunction and Dyslipidemia
Status: Enrolling
Updated: 8/14/2017
GSK Investigational Site
mi
from
Modesto, CA
Click here to add this to my saved trials
A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy, Safety, and Duration of Erection of Flexible-dose Vardenafil Administered for 12 Weeks Compared to Placebo in Subjects With Erectile Dysfunction and Dyslipidemia
Status: Enrolling
Updated:  8/14/2017
GSK Investigational Site
mi
from
Newport Beach, CA
A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy, Safety, and Duration of Erection of Flexible-dose Vardenafil Administered for 12 Weeks Compared to Placebo in Subjects With Erectile Dysfunction and Dyslipidemia
Status: Enrolling
Updated: 8/14/2017
GSK Investigational Site
mi
from
Newport Beach, CA
Click here to add this to my saved trials
A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy, Safety, and Duration of Erection of Flexible-dose Vardenafil Administered for 12 Weeks Compared to Placebo in Subjects With Erectile Dysfunction and Dyslipidemia
Status: Enrolling
Updated:  8/14/2017
GSK Investigational Site
mi
from
Orangevale, CA
A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy, Safety, and Duration of Erection of Flexible-dose Vardenafil Administered for 12 Weeks Compared to Placebo in Subjects With Erectile Dysfunction and Dyslipidemia
Status: Enrolling
Updated: 8/14/2017
GSK Investigational Site
mi
from
Orangevale, CA
Click here to add this to my saved trials
A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy, Safety, and Duration of Erection of Flexible-dose Vardenafil Administered for 12 Weeks Compared to Placebo in Subjects With Erectile Dysfunction and Dyslipidemia
Status: Enrolling
Updated:  8/14/2017
GSK Investigational Site
mi
from
Santa Ana, CA
A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Study Evaluating the Efficacy, Safety, and Duration of Erection of Flexible-dose Vardenafil Administered for 12 Weeks Compared to Placebo in Subjects With Erectile Dysfunction and Dyslipidemia
Status: Enrolling
Updated: 8/14/2017
GSK Investigational Site
mi
from
Santa Ana, CA
Click here to add this to my saved trials